These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32295876)

  • 1. The CD137 Ligand Is Important for Type 1 Diabetes Development but Dispensable for the Homeostasis of Disease-Suppressive CD137
    Foda BM; Ciecko AE; Serreze DV; Ridgway WM; Geurts AM; Chen YG
    J Immunol; 2020 Jun; 204(11):2887-2899. PubMed ID: 32295876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD137 Plays Both Pathogenic and Protective Roles in Type 1 Diabetes Development in NOD Mice.
    Forsberg MH; Ciecko AE; Bednar KJ; Itoh A; Kachapati K; Ridgway WM; Chen YG
    J Immunol; 2017 May; 198(10):3857-3868. PubMed ID: 28363905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant soluble CD137 prevents type one diabetes in nonobese diabetic mice.
    Kachapati K; Bednar KJ; Adams DE; Wu Y; Mittler RS; Jordan MB; Hinerman JM; Herr AB; Ridgway WM
    J Autoimmun; 2013 Dec; 47():94-103. PubMed ID: 24145149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model.
    Kachapati K; Adams DE; Wu Y; Steward CA; Rainbow DB; Wicker LS; Mittler RS; Ridgway WM
    J Immunol; 2012 Nov; 189(10):5001-15. PubMed ID: 23066155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD137 ligand reverse signaling skews hematopoiesis towards myelopoiesis during aging.
    Tang Q; Koh LK; Jiang D; Schwarz H
    Aging (Albany NY); 2013 Sep; 5(9):643-52. PubMed ID: 23945137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long and winding road: From mouse linkage studies to a novel human therapeutic pathway in type 1 diabetes.
    Rojas M; Heuer LS; Zhang W; Chen YG; Ridgway WM
    Front Immunol; 2022; 13():918837. PubMed ID: 35935980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T Cells Inhibit T Cell Activity by Downregulating CD137 Ligand via CD137 Trogocytosis.
    Luu K; Patwardhan MV; Zeng Q; Wickström SL; Lundqvist A; Schwarz H
    Cells; 2021 Feb; 10(2):. PubMed ID: 33572150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.
    Sgouroudis E; Albanese A; Piccirillo CA
    J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment.
    Bresson D; Fousteri G; Manenkova Y; Croft M; von Herrath M
    J Autoimmun; 2011 Dec; 37(4):342-51. PubMed ID: 22063316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model.
    Holohan DR; Van Gool F; Bluestone JA
    PLoS One; 2019; 14(10):e0217728. PubMed ID: 31647813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene targeting in NOD mouse embryos using zinc-finger nucleases.
    Chen YG; Forsberg MH; Khaja S; Ciecko AE; Hessner MJ; Geurts AM
    Diabetes; 2014 Jan; 63(1):68-74. PubMed ID: 23974926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD137 / CD137 ligand signalling regulates the immune balance: A potential target for novel immunotherapy of autoimmune diseases.
    Wong HY; Schwarz H
    J Autoimmun; 2020 Aug; 112():102499. PubMed ID: 32505443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dispensable role for 4-1BB and 4-1BBL in development of vaccinia virus-specific CD8 T cells.
    Zhao Y; Croft M
    Immunol Lett; 2012 Jan; 141(2):220-6. PubMed ID: 22037570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the CD137 ligand (CD137L) signaling pathway during Mycobacterium tuberculosis infection.
    Martínez Gómez JM; Koh VH; Yan B; Lin W; Ang ML; Rahim SZ; Pethe K; Schwarz H; Alonso S
    Immunobiology; 2014 Jan; 219(1):78-86. PubMed ID: 24091276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient Depletion of Foxp3
    Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
    Front Immunol; 2021; 12():720133. PubMed ID: 34447385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD137-CD137L interaction regulates atherosclerosis via cyclophilin A in apolipoprotein E-deficient mice.
    Li Y; Yan J; Wu C; Wang Z; Yuan W; Wang D
    PLoS One; 2014; 9(2):e88563. PubMed ID: 24520398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen-specific immunotherapy enhances CD8
    Tsai YG; Yang KD; Wen YS; Hung CH; Chien JW; Lin CY
    Pediatr Allergy Immunol; 2019 Aug; 30(5):531-539. PubMed ID: 30968455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Diabetogenic Immunity by IL-15-Activated Regulatory CD8 T Cells in Type 1 Diabetes.
    Stocks BT; Wilson CS; Marshall AF; Hoopes EM; Moore DJ
    J Immunol; 2019 Jul; 203(1):158-166. PubMed ID: 31127035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.
    Ly D; Mi QS; Hussain S; Delovitch TL
    J Immunol; 2006 Sep; 177(6):3695-704. PubMed ID: 16951329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD137-CD137L interaction modulates neointima formation and the phenotype transformation of vascular smooth muscle cells via NFATc1 signaling.
    Zhong W; Li B; Yang P; Chen R; Wang C; Wang Z; Shao C; Yuan W; Yan J
    Mol Cell Biochem; 2018 Feb; 439(1-2):65-74. PubMed ID: 28770466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.